Increased JNK activity was observed in osteosarcoma cells with high c-Jun and phosphorylated (activated) c-Jun present in higher-grade tumors, suggesting the role of the JNK signaling pathway in tumor progression [196]. The gene discussed is JUN; the disease is neoplasm.